BlueOcean Ventures

BlueOcean Ventures is a venture capital firm based in Geneva, Switzerland, with an additional office in Zurich. Established in 2008, the firm specializes in seed and early-stage investments, primarily targeting high technology companies in sectors such as medical devices, diagnostics, information and communication technology (ICT), medtech, environmental engineering, and life sciences. BlueOcean Ventures focuses its investments on companies located in Switzerland and Europe, with an interest in neighboring countries. The firm typically invests between 300,000 and 600,000 Swiss Francs in initial funding rounds, with total investments reaching up to 1.5 million Swiss Francs per company. It looks for companies valued between 3 million and 10 million Swiss Francs at the first round and often seeks a board seat in its portfolio companies. Additionally, BlueOcean Ventures provides operational and advisory support to entrepreneurs, assisting in areas such as management, negotiation, and divestment strategies. The investment horizon for the firm can extend up to ten years.

Sacha Haymoz

Advisor

Faris Sabeti

Advisor and Co-Founder

Emmanuel de Watteville

Co-Founder & Advisor

Thomas Zehnder

Advisor

Past deals in Zurich

CyanoGuard AG

Seed Round in 2020
Cyanoguard AG is a chemical technology company specialised in the development of novel toxin detection methods to improve environmental monitoring, food safety and health care in remote settings and locations. Its innovative technology enables fast and safe cyanide detection in food, waste water and other samples. Its method is selective and requires no special training and/or equipment. Equipped with the latest research, and with over six years of close collaboration with leading industry partners, the company is dedicated to resolve today's cyanide issues, offering fast and safe toxin detection in any setting at any time.

Ava

Series A in 2016
Ava AG, founded in 2014 and headquartered in Zurich, Switzerland, specializes in women's health by developing the Ava bracelet, a wearable sensor device designed for nighttime use. This bracelet measures various physiological parameters to accurately predict a woman's fertile window and ovulation. The information gathered by the bracelet is accessible through a complementary mobile application, enabling users to gain insights into their reproductive health. Ava is committed to empowering women by providing them with the tools necessary to make informed decisions regarding their health and well-being. The company also maintains an office in Hong Kong to support its operations.